The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries
In accordance with European regulation, medicines containing a new active substance to treat neurodegenerative diseases as well as autoimmune and other immune dysfunctions must be approved by the European Medicines Agency (EMA) through the centralized procedure before they can be marketed. However,...
Сохранить в:
Главные авторы: | , , , , , |
---|---|
Формат: | |
Опубликовано: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Предметы: | |
Online-ссылка: | Connect to this object online. |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
Шифр: |
A1234.567 |
---|---|
Копировать 1 | Доступно |